Fierce Biotech Summit 2024

Alice Valder Curran advises pharmaceutical manufacturers regarding drug pricing matters, with a particular emphasis on the Medicaid Drug Rebate Program, the Medicare average sales price (ASP) reporting requirement, the Health Resources and Services Administration (HRSA) 340B Drug... Read More →

Casarine (Cassie) Chong is Senior Vice President, Deputy General Counsel, Transactions for Bristol Myers Squibb. Cassie and her organization provide strategic and business-enabling support of all significant transactions, including mergers & acquisitions, venture investments and strategic... Read More →

Tess Cameron is a Principal on the Investment Team at RA Capital Management. Tess works on both public and private investments and serves on several company boards. Previously, Tess held finance leadership roles at Foghorn Therapeutics, Wave Life Sciences, and Biogen. Prior to joining... Read More →